Solexa listed on NASDAQ.(The Supply Line: For all the latest equipment news)(The Nasdaq Stock Market Inc.)(Brief article)

Developer of the 1G Genome Analyser, Solexa has been selected for addition to the NASDAQ Biotechnology Index. Securities included in the index must be listed on the NASDAQnational market and be classified according to the FTSE global classification system as either biotechnology or …